The Head of Biomarker Development will set the biomarker strategy, oversee assay development, and contribute to regulatory submissions for neuromuscular and rare diseases.

The Director, KOL Engagement will lead KOL relationship strategies, develop engagement initiatives, and ensure compliance during Scholar Rock's first U.S. launch.

The Senior Director, HCP Marketing will develop and execute the U.S. HCP marketing strategy for Scholar Rock's first commercial launch, ensuring effective brand strategy and orchestration across marketing and sales functions.

The Program Leader will oversee the development of emerging neuromuscular disease programs, bridging scientific development and commercialization while managing cross-functional teams and risks.

As Director of Pharmacoepidemiology, oversee observational studies, develop regulatory documents, and ensure safety analytics while collaborating cross-functionally.

The Director, CMC Project Management will lead global CMC activities for biologics projects, ensuring alignment with program goals, risk management, and collaboration across teams.

The Director of Field Force Operations will lead sales operations projects, enhance analytics, ensure data integrity, and drive commercial initiatives for effective growth in the pharmaceutical industry.

The Associate Director will enhance patient access to treatments for Spinal Muscular Atrophy by managing reimbursement processes and building relationships with healthcare providers and institutions.